Results 291 to 300 of about 1,290,956 (361)

Financial access, renewable energy, environmental quality, and health outcomes: mechanism evidence from BRICS countries. [PDF]

Front Public Health
Xie B, Xie B.
europepmc   +1 more source

Financing Central Cities: The Economics Underlying Fiscal Strategy Options

, 2017
Michael Wasylenko
openalex   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

From crisis response to country control: Restoring agency and sustainability in global health. [PDF]

PLoS Med
Okereke E.
europepmc   +1 more source

A Study on the Cross-Disciplinary Integration of Core Competencies in Enterprise Positions and University Curriculum Systems — Taking Economics and Finance as an Example

Shixiaoqi Liu
openalex   +2 more sources

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Correction: The impact of liquidity risk and credit risk on bank profitability during COVID-19. [PDF]

PLoS One
Haris M, Yao H, Fatima H, and the PLOS One Editors.   +3 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Evaluating the financial case for investing in, or divesting from, tobacco investments. [PDF]

Tob Control
Evans T, Sayed A, Van Walbeek C.
europepmc   +1 more source

Digital intelligence technology adoption and supply chain security of manufacturing firms: empirical evidence from China. [PDF]

Sci Rep
Yu Z, Liu H, Xing C.
europepmc   +1 more source